NDC 72786-111

OXBRYTA

Voxelotor

OXBRYTA is a Oral Tablet, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Global Blood Therapeutics Inc.. The primary component is Voxelotor.

• Product ID: 72786-111_0f829f12-5b00-4e7f-9261-377702f5a2a3
• NDC: 72786-111
• Product Type: Human Prescription Drug
• Proprietary Name: OXBRYTA
• Generic Name: Voxelotor
• Dosage Form: Tablet, For Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2021-12-17
• Marketing Category: NDA /
• Application Number: NDA216157
• Labeler Name: Global Blood Therapeutics Inc.
• Substance Name: VOXELOTOR
• Active Ingredient Strength: 300 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72786-111-02

60 TABLET, FOR SUSPENSION in 1 BOTTLE, PLASTIC (72786-111-02)

• Marketing Start Date: 2021-12-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "OXBRYTA" or generic name "Voxelotor"

NDC	Brand Name	Generic Name
72786-101	OXBRYTA	Voxelotor
72786-102	OXBRYTA	Voxelotor
72786-111	OXBRYTA	Voxelotor